Aller au contenu principal
Accès ouvert déclaré 2026 article

Diagnosis, mechanisms, and integrated Chinese-Western medicine prevention of oxaliplatin-induced peripheral neuropathy

0Citations signalées — pas une note de qualité
1Institutions déclarées
1Pays d’affiliation déclarés

Résumé fourni par la source

Oxaliplatin (OHP) is a third-generation platinum-based chemotherapeutic agent that frequently causes adverse effects, including chemotherapy-related gastrointestinal reactions, hypersensitivity, myelosuppression, and peripheral neurotoxicity.Among these adverse effects, OHP-induced peripheral neurotoxicity (OIPN) is the primary dose-limiting toxicity.OIPN significantly impairs patients' quality of life and interferes with the continuous administration of OHP, often resulting in dose reduction or treatment discontinuation.Given the current lack of effective monitoring and preventive strategies, this review constructs a complete three-stage integrated Chinese-Western medicine prevention system stratified by acute and chronic OIPN, proposes scenario-specific combined intervention regimens and interprets their synergistic molecular mechanisms.Integrated traditional Chinese and Western medicine demonstrates unique advantages in achieving synergistic prevention of OIPN.This combined strategy leverages precise risk assessment and targeted neuroprotection from Western medicine, while incorporating traditional Chinese medicine principles such as syndrome differentiation and preventive treatment.By overcoming limitations inherent to a single medical approach, this integrative strategy significantly reduces the incidence and severity of OIPN, improves patients' quality of life, and ensures smooth chemotherapy implementation.Thus, it opens a novel pathway for OIPN prevention in clinical practice.This review summarizes recent research advances in diagnostic methods, pathogenic mechanisms, and integrated Chinese-Western mecicine for the synergistic prevention of OIPN, while highlighting directions for future research.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Diagnosis, mechanisms, and integrated Chinese-Western medicine prevention of oxaliplatin-induced peripheral neuropathy
Date Crossref
04/09/2026
Éditeur
Baishideng Publishing Group Inc.
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Cancer Treatment and PharmacologyColorectal Cancer Treatments and StudiesBerberine and alkaloids research

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.